- Investing Ideas
- Egyptian Pharmaceuticals & Biotech Sustainable Track Record
Egyptian Pharmaceuticals & Biotech Sustainable Track Record
Results
6
Companies which have reinvested earnings to sustain 10% yearly growth over 5 years.
6 companies
Arab Drug
Market Cap: ج.م3.8b
Engages in the manufacture and sale of pharmaceutical products.
ADCI
ج.م305.04
7D
10.3%
1Y
138.1%
Alexandria For Pharmaceuticals & Chemical Industries
Market Cap: ج.م6.7b
Operates as a pharmaceutical company in Egypt.
AXPH
ج.م1,330.10
7D
5.6%
1Y
96.9%
Memphis Pharmaceuticals & Chemical Industries
Market Cap: ج.م9.1b
Engages in the research, development, manufacture, marketing, and distribution of pharmaceutical products for human and veterinary use in Egypt and internationally.
MPCI
ج.م374.00
7D
17.7%
1Y
203.3%
EI- Nile for Pharmaceuticals and Chemical Industries
Market Cap: ج.م23.0b
Develops, produces, and sells pharmaceutical products in Egypt.
NIPH
ج.م398.00
7D
46.9%
1Y
745.2%
Egyptian International Pharmaceutical Industries
Market Cap: ج.م25.9b
Manufactures and sells pharmaceutical ampoules in Egypt and internationally.
PHAR
ج.م142.51
7D
9.6%
1Y
173.9%
Kahira Pharmaceuticals & Chemical Industries
Market Cap: ج.م8.3b
Manufactures, packages, distributes, and trades in pharmaceutical products in Egypt and internationally.
CPCI
ج.م537.52
7D
10.3%
1Y
153.2%